STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis

Steve Oghumu, Gaurav Gupta, Heidi M. Snider, Sanjay Varikuti, César A. Terrazas, Tracey L. Papenfuss, Mark Kaplan, Abhay R. Satoskar

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We and others have previously shown that IL-12 is indispensable for immunity and is required for the optimal antiparasitic activity of antimonials in experimental visceral leishmaniasis caused by Leishmania donovani. Here we investigated the role of STAT4 in immunity against L. donovani using STAT4 knockout mice and also determined the effect of STAT4 deficiency in response to antimonial therapy. Upon infection with L. donovani, stat4-/- BALB/c and C57BL/6 mice showed enhanced susceptibility to Leishmania during late time points of infection which was associated with a marked reduction in Th1 responses and hepatic immunopathology. Interestingly, these defects in Th1 responses in stat4-/- did not impair the antimonial chemotherapy as both stat4-/- and WT mice showed comparable levels of parasite clearance from the liver and spleen. These findings highlight the role of STAT4 in immunity to L. donovani infection and also provide evidence that STAT4 is dispensable for antimonial-based chemotherapy.

Original languageEnglish
Pages (from-to)450-459
Number of pages10
JournalEuropean Journal of Immunology
Volume44
Issue number2
DOIs
StatePublished - Feb 2014

Fingerprint

Leishmania donovani
Visceral Leishmaniasis
Immunity
Infection
Antiparasitic Agents
Drug Therapy
Leishmania
Liver
Interleukin-12
Inbred C57BL Mouse
Knockout Mice
Parasites
Spleen
Therapeutics

Keywords

  • IFN-γ
  • IL-12
  • Leishmania donovani
  • Sodium stibogluconate
  • STAT4 chemotherapy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Oghumu, S., Gupta, G., Snider, H. M., Varikuti, S., Terrazas, C. A., Papenfuss, T. L., ... Satoskar, A. R. (2014). STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis. European Journal of Immunology, 44(2), 450-459. https://doi.org/10.1002/eji.201343477

STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis. / Oghumu, Steve; Gupta, Gaurav; Snider, Heidi M.; Varikuti, Sanjay; Terrazas, César A.; Papenfuss, Tracey L.; Kaplan, Mark; Satoskar, Abhay R.

In: European Journal of Immunology, Vol. 44, No. 2, 02.2014, p. 450-459.

Research output: Contribution to journalArticle

Oghumu, Steve ; Gupta, Gaurav ; Snider, Heidi M. ; Varikuti, Sanjay ; Terrazas, César A. ; Papenfuss, Tracey L. ; Kaplan, Mark ; Satoskar, Abhay R. / STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis. In: European Journal of Immunology. 2014 ; Vol. 44, No. 2. pp. 450-459.
@article{693208851d8447058bd19e3b400c3f34,
title = "STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis",
abstract = "We and others have previously shown that IL-12 is indispensable for immunity and is required for the optimal antiparasitic activity of antimonials in experimental visceral leishmaniasis caused by Leishmania donovani. Here we investigated the role of STAT4 in immunity against L. donovani using STAT4 knockout mice and also determined the effect of STAT4 deficiency in response to antimonial therapy. Upon infection with L. donovani, stat4-/- BALB/c and C57BL/6 mice showed enhanced susceptibility to Leishmania during late time points of infection which was associated with a marked reduction in Th1 responses and hepatic immunopathology. Interestingly, these defects in Th1 responses in stat4-/- did not impair the antimonial chemotherapy as both stat4-/- and WT mice showed comparable levels of parasite clearance from the liver and spleen. These findings highlight the role of STAT4 in immunity to L. donovani infection and also provide evidence that STAT4 is dispensable for antimonial-based chemotherapy.",
keywords = "IFN-γ, IL-12, Leishmania donovani, Sodium stibogluconate, STAT4 chemotherapy",
author = "Steve Oghumu and Gaurav Gupta and Snider, {Heidi M.} and Sanjay Varikuti and Terrazas, {C{\'e}sar A.} and Papenfuss, {Tracey L.} and Mark Kaplan and Satoskar, {Abhay R.}",
year = "2014",
month = "2",
doi = "10.1002/eji.201343477",
language = "English",
volume = "44",
pages = "450--459",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "2",

}

TY - JOUR

T1 - STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis

AU - Oghumu, Steve

AU - Gupta, Gaurav

AU - Snider, Heidi M.

AU - Varikuti, Sanjay

AU - Terrazas, César A.

AU - Papenfuss, Tracey L.

AU - Kaplan, Mark

AU - Satoskar, Abhay R.

PY - 2014/2

Y1 - 2014/2

N2 - We and others have previously shown that IL-12 is indispensable for immunity and is required for the optimal antiparasitic activity of antimonials in experimental visceral leishmaniasis caused by Leishmania donovani. Here we investigated the role of STAT4 in immunity against L. donovani using STAT4 knockout mice and also determined the effect of STAT4 deficiency in response to antimonial therapy. Upon infection with L. donovani, stat4-/- BALB/c and C57BL/6 mice showed enhanced susceptibility to Leishmania during late time points of infection which was associated with a marked reduction in Th1 responses and hepatic immunopathology. Interestingly, these defects in Th1 responses in stat4-/- did not impair the antimonial chemotherapy as both stat4-/- and WT mice showed comparable levels of parasite clearance from the liver and spleen. These findings highlight the role of STAT4 in immunity to L. donovani infection and also provide evidence that STAT4 is dispensable for antimonial-based chemotherapy.

AB - We and others have previously shown that IL-12 is indispensable for immunity and is required for the optimal antiparasitic activity of antimonials in experimental visceral leishmaniasis caused by Leishmania donovani. Here we investigated the role of STAT4 in immunity against L. donovani using STAT4 knockout mice and also determined the effect of STAT4 deficiency in response to antimonial therapy. Upon infection with L. donovani, stat4-/- BALB/c and C57BL/6 mice showed enhanced susceptibility to Leishmania during late time points of infection which was associated with a marked reduction in Th1 responses and hepatic immunopathology. Interestingly, these defects in Th1 responses in stat4-/- did not impair the antimonial chemotherapy as both stat4-/- and WT mice showed comparable levels of parasite clearance from the liver and spleen. These findings highlight the role of STAT4 in immunity to L. donovani infection and also provide evidence that STAT4 is dispensable for antimonial-based chemotherapy.

KW - IFN-γ

KW - IL-12

KW - Leishmania donovani

KW - Sodium stibogluconate

KW - STAT4 chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84893585795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893585795&partnerID=8YFLogxK

U2 - 10.1002/eji.201343477

DO - 10.1002/eji.201343477

M3 - Article

VL - 44

SP - 450

EP - 459

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 2

ER -